%0 Journal Article %A Ellen Ø Carlsen %A Ida Henriette Caspersen %A Lill Trogstad %A Håkon K Gjessing %A Per Magnus %T Public adherence to governmental recommendations regarding quarantine and testing for COVID-19 in two Norwegian cohorts %D 2020 %R 10.1101/2020.12.18.20248405 %J medRxiv %P 2020.12.18.20248405 %X Background Combatting the COVID-19 pandemic relies at present on non-pharmacological interventions. Governments are using various approaches from general advice to full lockdown. There is a need to describe and understand adherence to public health actions.Methods Participants from two ongoing cohorts, the Norwegian Mother, Father and Child Cohort Study (MoBa) and The Norwegian Influenza Pregnancy Cohort (NorFlu), answered questionnaires every 14 days since March 2020. From the summer of 2020, testing for presence of SARS-CoV-2 became easily available. Recommendations were that respiratory symptoms should lead to testing, and that confirmed or suspected COVID-19 should be followed by quarantine. We estimated the adherence to these guidelines in responses from cohort participants in the period August to October 2020.Results Less than 40% of men who were ill and less than 45% of women who were ill, tested themselves for SARS-CoV-2 during the same 14-day periods. Among subjects tested for COVID-19, about 53% of men and 59% of women reported quarantine. For subjects with a confirmed or suspected COVID-19 diagnosis, the proportions quarantined were 65% for men and 72% for women.Conclusions Public adherence to governmental recommendations regarding testing and quarantine were lower than expected in a country with high trust in government. This leaves considerable room for improvement in adherence, possibly reducing the need for more restrictive interventions.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was funded in part by the Norwegian Research Council Centres of Excellence Funding Scheme (no. 262700) and by project number 312721, COVID-19 in Norway: A real-time analytical pipeline for preparedness, planning and response during the COVID-19 pandemic in Norway.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Data collection in MoBa was licensed by the Norwegian Data Protection Agency and approved by The Regional Committees for Medical and Health Research Ethics. The data collection in the MoBa cohort is regulated by the Norwegian Health Registry Act.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).Yes I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data underlying this article are available for analysis after approval from a Norwegian ethics committee and application to the Norwegian Institute of Public Health. %U https://www.medrxiv.org/content/medrxiv/early/2020/12/20/2020.12.18.20248405.full.pdf